KR102168533B1 - Cosmetic composition for whitening or improving the facial color containing herb extracts - Google Patents
Cosmetic composition for whitening or improving the facial color containing herb extracts Download PDFInfo
- Publication number
- KR102168533B1 KR102168533B1 KR1020140081566A KR20140081566A KR102168533B1 KR 102168533 B1 KR102168533 B1 KR 102168533B1 KR 1020140081566 A KR1020140081566 A KR 1020140081566A KR 20140081566 A KR20140081566 A KR 20140081566A KR 102168533 B1 KR102168533 B1 KR 102168533B1
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- whitening
- cosmetic composition
- antler
- thyme
- Prior art date
Links
- 239000000284 extract Substances 0.000 title claims abstract description 73
- 239000000203 mixture Substances 0.000 title claims abstract description 58
- 239000002537 cosmetic Substances 0.000 title claims abstract description 28
- 230000002087 whitening effect Effects 0.000 title claims abstract description 28
- 230000001815 facial effect Effects 0.000 title 1
- 210000003056 antler Anatomy 0.000 claims abstract description 41
- 235000007303 Thymus vulgaris Nutrition 0.000 claims abstract description 40
- 239000001585 thymus vulgaris Substances 0.000 claims abstract description 40
- 241000209020 Cornus Species 0.000 claims abstract description 37
- 239000004480 active ingredient Substances 0.000 claims abstract description 8
- 241000246358 Thymus Species 0.000 claims abstract 6
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 claims description 56
- 239000002904 solvent Substances 0.000 claims description 23
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 14
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 12
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 12
- 229940058015 1,3-butylene glycol Drugs 0.000 claims description 10
- 235000019437 butane-1,3-diol Nutrition 0.000 claims description 10
- 201000001441 melanoma Diseases 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 10
- 241000063156 Squatina squatina Species 0.000 claims description 9
- 235000013336 milk Nutrition 0.000 claims description 9
- 239000008267 milk Substances 0.000 claims description 9
- 210000004080 milk Anatomy 0.000 claims description 9
- 230000006872 improvement Effects 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 244000061520 Angelica archangelica Species 0.000 claims 2
- 230000002401 inhibitory effect Effects 0.000 abstract description 9
- 230000008099 melanin synthesis Effects 0.000 abstract description 5
- 230000001747 exhibiting effect Effects 0.000 abstract description 2
- 240000002657 Thymus vulgaris Species 0.000 description 34
- 230000000694 effects Effects 0.000 description 22
- 210000003491 skin Anatomy 0.000 description 14
- 210000004027 cell Anatomy 0.000 description 13
- 238000000605 extraction Methods 0.000 description 13
- 239000003921 oil Substances 0.000 description 13
- 235000019198 oils Nutrition 0.000 description 13
- -1 antler Substances 0.000 description 11
- 238000009472 formulation Methods 0.000 description 11
- 240000002045 Guettarda speciosa Species 0.000 description 10
- 241000282994 Cervidae Species 0.000 description 9
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 9
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 9
- 239000012153 distilled water Substances 0.000 description 7
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- 238000001035 drying Methods 0.000 description 6
- 241000411851 herbal medicine Species 0.000 description 6
- 102000003425 Tyrosinase Human genes 0.000 description 5
- 108060008724 Tyrosinase Proteins 0.000 description 5
- 229960000271 arbutin Drugs 0.000 description 5
- 238000005194 fractionation Methods 0.000 description 5
- 210000002510 keratinocyte Anatomy 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 5
- 239000011148 porous material Substances 0.000 description 5
- 238000002791 soaking Methods 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 4
- HLXRWTJXGMHOFN-XJSNKYLASA-N Verbenalin Chemical compound O([C@@H]1OC=C([C@H]2C(=O)C[C@H](C)[C@H]21)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HLXRWTJXGMHOFN-XJSNKYLASA-N 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- 239000000839 emulsion Substances 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- 210000002752 melanocyte Anatomy 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000012676 herbal extract Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 239000000377 silicon dioxide Substances 0.000 description 3
- 239000000344 soap Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 235000015112 vegetable and seed oil Nutrition 0.000 description 3
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- HLXRWTJXGMHOFN-UHFFFAOYSA-N Verbenalin Natural products C12C(C)CC(=O)C2C(C(=O)OC)=COC1OC1OC(CO)C(O)C(O)C1O HLXRWTJXGMHOFN-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- 239000001058 brown pigment Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 229940074391 gallic acid Drugs 0.000 description 2
- 235000004515 gallic acid Nutrition 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000001694 spray drying Methods 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 2
- 229940096998 ursolic acid Drugs 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- SXFBQAMLJMDXOD-UHFFFAOYSA-N (+)-hydrogentartrate bitartrate salt Chemical compound OC(=O)C(O)C(O)C(O)=O.OC(=O)C(O)C(O)C(O)=O SXFBQAMLJMDXOD-UHFFFAOYSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical class CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241000544270 Angelica acutiloba Species 0.000 description 1
- 108010087765 Antipain Proteins 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 240000004385 Centaurea cyanus Species 0.000 description 1
- 235000005940 Centaurea cyanus Nutrition 0.000 description 1
- 241000142975 Cornaceae Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- AMBQHHVBBHTQBF-UHFFFAOYSA-N Loganin Natural products C12C(C)C(O)CC2C(C(=O)OC)=COC1OC1OC(CO)C(O)C(O)C1O AMBQHHVBBHTQBF-UHFFFAOYSA-N 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 240000009164 Petroselinum crispum Species 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 244000044822 Simmondsia californica Species 0.000 description 1
- 235000004433 Simmondsia californica Nutrition 0.000 description 1
- 206010070835 Skin sensitisation Diseases 0.000 description 1
- 241000542126 Squatina japonica Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 206010047642 Vitiligo Diseases 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 239000001180 angelica archangelica l. root extract Substances 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- SDNYTAYICBFYFH-TUFLPTIASA-N antipain Chemical compound NC(N)=NCCC[C@@H](C=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 SDNYTAYICBFYFH-TUFLPTIASA-N 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- 238000004061 bleaching Methods 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- HTRXGEPDTFSKLI-UHFFFAOYSA-N butanoic acid;ethyl acetate Chemical compound CCCC(O)=O.CCOC(C)=O HTRXGEPDTFSKLI-UHFFFAOYSA-N 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229940081733 cetearyl alcohol Drugs 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 208000023652 chronic gastritis Diseases 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000002079 cooperative effect Effects 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 230000005016 dendritic process Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- UBHWBODXJBSFLH-UHFFFAOYSA-N hexadecan-1-ol;octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO.CCCCCCCCCCCCCCCCCCO UBHWBODXJBSFLH-UHFFFAOYSA-N 0.000 description 1
- 238000007602 hot air drying Methods 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 229960004337 hydroquinone Drugs 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- AMBQHHVBBHTQBF-UOUCRYGSSA-N loganin Chemical compound O([C@@H]1OC=C([C@H]2C[C@H](O)[C@H](C)[C@H]21)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O AMBQHHVBBHTQBF-UOUCRYGSSA-N 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 230000000324 neuroprotective effect Effects 0.000 description 1
- 239000012454 non-polar solvent Substances 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 229940124595 oriental medicine Drugs 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 235000011197 perejil Nutrition 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 238000004161 plant tissue culture Methods 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 239000003531 protein hydrolysate Substances 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 231100000370 skin sensitisation Toxicity 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229940005623 thyme preparation Drugs 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/40—Cornaceae (Dogwood family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Birds (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
본 발명은 미백 또는 안색 개선용 조성물에 관한 것이다. 본 발명에 따른 일당귀, 산수유, 녹용, 선백리향 또는 이들의 혼합물의 추출물을 유효성분으로 포함하는 조성물은 멜라닌 합성을 억제하여 미백 효과를 나타냄으로써 미백 또는 안색개선용 화장료 조성물로 사용 가능하다.The present invention relates to a composition for whitening or improving complexion. The composition comprising the extract of Angelicae, Cornus, antler, Sun thyme or a mixture thereof according to the present invention as an active ingredient can be used as a cosmetic composition for whitening or improving complexion by exhibiting a whitening effect by inhibiting melanin synthesis.
Description
본 발명은 한약재 추출물을 포함하는 미백 또는 안색 개선용 화장료 조성물에 관한 것으로, 더욱 상세하게는 일당귀, 산수유, 녹용 및 선백리향으로 이루어진 군으로부터 선택되는 1종 이상의 추출물 또는 이의 분획물을 유효성분으로 포함하는 미백 또는 안색 개선용 화장료 조성물에 관한 것이다.
The present invention relates to a cosmetic composition for whitening or improving complexion comprising an herbal extract, and more particularly, comprising one or more extracts selected from the group consisting of Angelicae, Cornus, antler and Sun thyme as an active ingredient. It relates to a cosmetic composition for whitening or improving complexion.
사람의 피부색을 결정하는 멜라닌(melanin)은 멜라노사이트(melanocyte)에서 생성된다. 구체적으로 멜라닌은 생체 내 존재하는 아미노산인 티로신(tyrosine)을 기질로 하여, 멜라노사이트에 존재하는 티로시나제(tyrosinase) 등의 효소에 의한 중합화 산화 반응으로 형성되는 흑갈색의 색소이다. 이렇게 형성된 멜라닌은 멜라노사이트의 수지상 돌기를 통하여 케라티노사이트(keratinocyte)라는 표피세포로 이동하게 된다. 케라티노사이트로 이동한 멜라닌은 케라티노사이트가 표피에서 떨어져 나갈 때에 피부에서 함께 떨어져 나감으로써 제거될 수 있다. 그러나, 생체 내에 멜라닌을 분해하는 효소가 없기 때문에 한번 형성된 멜라닌은 생체 내에서는 분해되지 않는다. 따라서, 피부를 밝게 하기 위하여는 멜라닌의 생성을 억제하는 것이 관건이라 할 수 있다.Melanin, which determines the color of human skin, is produced in melanocytes. Specifically, melanin is a dark brown pigment formed by polymerization and oxidation reactions by enzymes such as tyrosinase present in melanocytes using tyrosine, an amino acid present in vivo, as a substrate. The melanin formed in this way moves to epidermal cells called keratinocytes through dendritic processes of melanocytes. Melanin that has migrated to keratinocytes can be removed by releasing them together from the skin as the keratinocytes break away from the epidermis. However, since there is no enzyme that degrades melanin in the living body, melanin once formed is not degraded in vivo. Therefore, in order to brighten the skin, it can be said that suppressing the production of melanin is the key.
화장품으로서의 미백제의 연구는 최근 정서적으로 흰 피부를 선호하는 동양권의 생활 수준 향상과 더불어 피부 흑화가 자외선에 의한 피부 노화로 인식되면서 그 필요성이 점차 증대되고 있다. 그에 따라 아스코르빈산(ascorbic acid), 하이드로퀴논(hydroquinone), 글루타치온(glutathione), 알부틴(arbutin) 등의 티로시나아제 저해 활성을 나타내는 물질들이 화장료나 의약품에 배합되어 사용되어 왔으나(특허문헌 1 및 2), 이들 중 대부분의 것은 효과가 불충분하거나 제형상 불안정한 면이 있어 활용도가 떨어진다. 특히 하이드로퀴논과 같은 화합물은 강한 탈색 작용을 나타내며 그 자체가 피부 감작성을 가지고 있어 피부 알레르기 등을 유발할 수 있고, 정상적인 피부의 기능을 변화시켜 백반증을 유발하는 등의 부작용을 나타내어 피부에 대한 안전성 측면에서 그 사용이 제한되고 있다.The need for research on whitening agents as cosmetics is gradually increasing as the living standards of the Eastern world, which emotionally prefer white skin, are improved, and skin blackening is recognized as skin aging due to ultraviolet rays. Accordingly, substances exhibiting tyrosinase inhibitory activity, such as ascorbic acid, hydroquinone, glutathione, and arbutin, have been formulated and used in cosmetics and pharmaceuticals (Patent Document 1 and 2) Most of these have insufficient effects or are unstable in their formulation, so their utilization is poor. In particular, compounds such as hydroquinone exhibit a strong bleaching action and have skin sensitization by themselves, which can cause skin allergies and other side effects, such as causing vitiligo by changing the normal skin function. Its use is limited in.
또한, 상기와 같이 티로시나아제의 활성을 저해하는 물질이라 하더라도 이러한 물질이 각질 형성 세포인 케라티노사이트에 작용하여 멜라닌의 생합성을 촉진시키는 인자의 생성을 증가시킨다면, 결과적으로 미백 작용은 약화되거나 오히려 악효과를 거둘 수 있기 때문에 단순히 티로시나아제의 활성 저해제가 좋은 미백제라고 볼 수 없으며, 이에 많은 티로시나아제 저해제가 개발되고 있으나 거의 대부분이 우수한 미백 효과를 나타내지 않는 것으로 알려져 있다. In addition, even if it is a substance that inhibits the activity of tyrosinase as described above, if these substances act on keratinocytes, which are keratinocytes, to increase the production of factors that promote the biosynthesis of melanin, as a result, the whitening effect is weakened or rather Since it can have an adverse effect, simply an inhibitor of tyrosinase activity cannot be considered as a good whitening agent. Accordingly, many tyrosinase inhibitors have been developed, but most of them are known to exhibit no excellent whitening effect.
이러한 배경하에, 본 발명자들은 천연에 존재하는 천연 자원들로부터 독성이 없고 피부 상태 개선 효과가 우수한 물질에 관하여 연구를 수행하였으며, 이에 일당귀, 산수유, 녹용 및 선백리향으로 이루어진 군으로부터 선택되는 1종 이상의 한약재 추출물이 멜라닌 합성 억제 효능을 나타냄을 규명하여, 이를 활용한 미백 또는 안색 개선용 화장료 조성물을 완성하기에 이르렀다.
Under this background, the present inventors have conducted research on substances that are not toxic from natural resources and have excellent skin condition improvement effect, and thus at least one selected from the group consisting of angelica, cornus, antler and thyme It was found that the herbal medicine extract exhibits the inhibitory effect of melanin synthesis, and a cosmetic composition for whitening or improving complexion using it has been completed.
본 발명의 목적은 일당귀, 산수유, 녹용 및 선백리향으로 이루어진 군으로부터 선택되는 1종 이상의 추출물 또는 이의 분획물을 유효성분으로 포함하는 것을 특징으로 하는 미백 또는 안색 개선용 화장료 조성물을 제공하는 것이다.
It is an object of the present invention to provide a cosmetic composition for whitening or improving complexion, characterized in that it comprises one or more extracts selected from the group consisting of angelfish, cornus, deer antler and sun thyme as an active ingredient.
상기 과제를 해결하기 위하여, 본 발명의 일 구현예로서, 일당귀, 산수유, 녹용 및 선백리향으로 이루어진 군으로부터 선택되는 1종 이상의 추출물 또는 이의 분획물을 유효성분으로 포함하는 것을 특징으로 하는 미백 또는 안색 개선용 화장료 조성물을 제공한다.In order to solve the above problems, as an embodiment of the present invention, whitening or complexion improvement, characterized in that it comprises one or more extracts selected from the group consisting of angelfish, cornus, antler and sun thyme as an active ingredient. It provides a cosmetic composition for.
본 발명의 다른 구현예에서, 일당귀, 산수유, 녹용 및 선백리향의 혼합추출물 또는 이의 분획물을 유효성분으로 포함하는 것을 특징으로 하는 미백 또는 안색 개선용 화장료 조성물을 제공한다.In another embodiment of the present invention, it provides a cosmetic composition for whitening or improving complexion, characterized in that it comprises a mixed extract or a fraction thereof of an angelfish, cornus milk, antler and sun thyme as an active ingredient.
본 발명의 또 다른 구현예에서, 상기 일당귀, 산수유, 녹용 및 선백리향의 혼합 비율은 중량 기준으로 10 내지 40 : 10 내지 40 : 10 내지 40 : 10 내지 40, 더욱 바람직하기로 20 내지 30 : 20 내지 30 : 20 내지 30 : 20 내지 30일 수 있다.In another embodiment of the present invention, the mixing ratio of the angelfish, cornus milk, antler and thyme is 10 to 40: 10 to 40: 10 to 40: 10 to 40, more preferably 20 to 30: 20 by weight. To 30: 20 to 30: it may be 20 to 30.
본 발명의 일당귀(Angelica acutiloba)는 미나리과에 속한 다년생 초본인 대화당귀의 뿌리를 건조시킨 것으로, 왜당귀로도 불리며, 그 맛은 달고 매우며, 성질은 따뜻하다. 일당귀는 최초 일본에 수출할 목적으로 도입되어 재배되었으나, 최근에는 잎에 특유한 향과 풍부한 무기물과 비타민이 보고되면서 기능성 쌈채소로 각광받고 있다. 효능적인 측면에서는, 신경보호효과, 진통, 소염 효과 등의 유용 약리효과가 알려져 있다.Angelica acutiloba of the present invention is a dried root of Daehwa Angelica, a perennial herb belonging to the Parsley family, and is also called Japanese Angelica, and its taste is sweet and very, and its nature is warm. Ildangwi was first introduced and cultivated for export to Japan, but in recent years, it has been in the spotlight as a functional ssam vegetable with its unique fragrance and rich minerals and vitamins on its leaves. In terms of efficacy, useful pharmacological effects such as neuroprotective effects, analgesics, and anti-inflammatory effects are known.
본 발명의 산수유(Corni Fructus)는 층층 나무과에 속하며, 10 ~ 11월 과실이 성숙하면 채취하여 가지와 꼭지를 제거한 후, 약한 불로 말린 다음 식혀서 씨는 버리고 과육을 취하여 다시 햇볕이나 약한 불로 말려, 그늘에 보관한다. 한방에서는 자양, 강장, 수렴약으로 사용하며, 주성분으로는 모로니사이드(Morroniside), 로가닌(Loganin), 코르닌(Cornin(Verbenalin)), 사포닌(Saponin), 탄닌(Tanin), 우르솔닉산(Ursolic acid), 갈릭산(Gallic acid), 마릭산(Malic acid), 타타릭산(Tartaric acid) 및 비타민 A 등이 들어있다. Corni Fructus of the present invention belongs to the dogwood family, and when the fruit matures in October to November, it is collected, removed branches and stems, dried over low heat, cooled, and discarded, the seeds are discarded, and the pulp is dried again in sunlight or low heat, and shade Keep in. In oriental medicine, it is used as a nutrient, tonic, and astringent medicine, and the main ingredients are Moroniside, Loganin, Cornin (Verbenalin), Saponin, Tannin, and ursolic acid. (Ursolic acid), gallic acid (Gallic acid), mariic acid (Malic acid), tartaric acid (Tartaric acid) and vitamin A, etc. are contained.
본 발명의 녹용(cervi parvum cornu)은 숫사슴의 갓 자란 뿔을 채취 가공하여 건조한 한약재로서 오랫동안 보혈강장제로 널리 사용되어 온 생약재이다. 녹용은 동물실험 및 임상실험 결과, 소아의 성장 발육촉진 효과, 노화억제 효과, 조혈기능 효과, 심장기능 개선 효과, 항근육피로 효과 및 항진통 효과등이 있는 것으로 밝혀졌다.The antler (cervi parvum cornu) of the present invention is a herbal medicine that has been widely used as a blood tonic for a long time as a dried herbal medicine obtained by collecting and processing freshly grown horns of a stag. As a result of animal and clinical trials, deer antler was found to have an effect of promoting growth and development in children, an anti-aging effect, an effect of hematopoietic function, an effect of improving heart function, an anti-muscular fatigue effect, and an anti-pain effect.
본 발명의 선백리향(Thymus vulgaris)은 다년생의 상록수로 45cm 정도까지 자라며 가지가 많다. 잎은 회 녹색이며 아로마 향을 내고 꽃은 옅은 보라색 혹은 하얀색이다. 주로 호흡기 장애, 소화기 장애에 쓰이며 영국허브약전에서는 소화불량, 만성위염, 기관지염 등에 사용할 수 있다고 나와 있다. The thyme of the present invention (Thymus vulgaris) is a perennial evergreen tree that grows to about 45cm and has many branches. The leaves are grayish green and have an aromatic scent, and the flowers are pale purple or white. It is mainly used for respiratory and digestive problems, and the British Herbal Pharmacopoeia says that it can be used for indigestion, chronic gastritis, and bronchitis.
본 발명에서 사용되는 용어, "추출물"은 상기 일당귀, 산수유, 녹용, 선백리향 또는 이들의 혼합물의 추출처리에 의하여 얻어지는 추출액, 상기 추출액의 희석액이나 농축액, 상기 추출액을 건조하여 얻어지는 건조물, 상기 추출액의 조정제물이나 정제물, 또는 이들의 혼합물 등, 추출액 자체 및 추출액을 이용하여 형성 가능한 모든 제형의 추출물을 포함한다.As used in the present invention, the term "extract" refers to an extract obtained by extraction treatment of the Angelica Angelica, Cornus deer antler, Sun thyme or a mixture thereof, a dilution or concentrate of the extract, a dried product obtained by drying the extract, and It includes the extract of all formulations that can be formed using the extract itself and the extract, such as a crude product, a purified product, or a mixture thereof.
본 발명의 상기 추출물은, 상기 각각의 해당 식물의 천연, 잡종 또는 변종 식물로부터 추출될 수 있고, 식물 조직 배양물로부터도 추출이 가능하다.The extract of the present invention may be extracted from natural, hybrid or variant plants of the respective plants, and may be extracted from plant tissue culture.
본 발명의 상기 일당귀, 산수유, 녹용, 선백리향 또는 이들의 혼합물의 추출에 있어서, 상기 추출하는 방법은 특별히 제한되지 아니하며, 당해 기술 분야에서 통상적으로 사용하는 방법에 따라 추출할 수 있다. 상기 추출 방법의 비제한적인 예로는, 열수 추출법, 초음파 추출법, 여과법, 환류 추출법 등을 들 수 있으며, 이들은 단독으로 수행되거나 2 종 이상의 방법을 병용하여 수행될 수 있다.In the extraction of the angelfish, cornus, antler, thyme or a mixture thereof of the present invention, the extraction method is not particularly limited, and may be extracted according to a method commonly used in the art. Non-limiting examples of the extraction method include a hot water extraction method, an ultrasonic extraction method, a filtration method, a reflux extraction method, and the like, which may be performed alone or in combination of two or more methods.
본 발명에서 상기 일당귀, 산수유, 녹용, 선백리향 또는 이들의 혼합물을 추출하는 데 사용되는 추출 용매의 종류는 특별히 제한되지 아니하며, 당해 기술 분야에서 공지된 임의의 용매를 사용할 수 있다. 상기 추출 용매의 비제한적인 예로는 물; 메탄올, 에탄올, 프로필알코올, 부틸알코올 등의 C1 내지 C4의 저급 알코올; 글리세린, 부틸렌글리콜, 프로필렌글리콜 등의 다가 알코올; 및 메틸아세테이트, 에틸아세테이트, 아세톤, 벤젠, 헥산, 디에틸에테르, 디클로로메탄 등의 탄화수소계 용매; 또는 이들의 혼합물을 사용할 수 있으며, 바람직하게, 물, 저급알코올, 1,3-부틸렌글리콜, 에틸아세테이트를 단독으로 사용하거나 2종 이상 혼합하여 사용할 수 있다. 본 발명에서 일당귀, 산수유, 녹용, 선백리향의 한약재를 추출하는 용매로 보다 바람직하게는 물(또는 증류수), 1,3-부틸렌 글리콜 또는 이들의 혼합용매를 사용할 수 있다. 상기 용매를 사용하여 일당귀, 산수유, 녹용, 선백리향의 한약재를 1회 이상 추출하여 용매 추출물을 제조할 수 있으며, 상기 용매 추출물을 감압 증류한 후 동결건조 또는 분무 건조하여 얻은 건조 추출물을 제조할 수 있다. 본 발명의 구체적인 일 실시예에서는 추출용매(증류수:1,3-부틸렌글리콜 = 7:3)를 사용하여 일당귀추출물; 산수유추출물; 녹용추출물; 선백리향추출물 및 일당귀, 산수유, 녹용 및 선백리향의 혼합추출물을 제조하였다(실시예 1 내지 실시예 5).In the present invention, the kind of the extraction solvent used to extract the mono angelica, cornus oil, antler, thyme or a mixture thereof is not particularly limited, and any solvent known in the art may be used. Non-limiting examples of the extraction solvent include water; C 1 to C 4 lower alcohols such as methanol, ethanol, propyl alcohol, and butyl alcohol; Polyhydric alcohols such as glycerin, butylene glycol, and propylene glycol; And hydrocarbon solvents such as methyl acetate, ethyl acetate, acetone, benzene, hexane, diethyl ether, and dichloromethane; Or a mixture thereof may be used, and preferably, water, lower alcohol, 1,3-butylene glycol, and ethyl acetate may be used alone or in combination of two or more. In the present invention, more preferably, water (or distilled water), 1,3-butylene glycol, or a mixed solvent thereof may be used as a solvent for extracting herbal medicinal herbs such as Angelicae, Cornus oil, Deer antler, and Sun thyme. Using the solvent, a solvent extract can be prepared by extracting medicinal herbs such as Angelicae, Cornus, antler, and Seon thyme at least once, and a dry extract obtained by distilling the solvent extract under reduced pressure and then freeze drying or spray drying can be prepared. have. In a specific embodiment of the present invention, a monosaccharide extract using an extraction solvent (distilled water: 1,3-butylene glycol = 7:3); Cornus extract; Antler extract; Sun thyme extract and mixed extracts of Japanese angelica, cornus, antler and sun thyme were prepared (Examples 1 to 5).
본 발명에서 열수 추출 또는 냉침 추출한 추출물은 부유하는 고체 입자를 제거하기 위해 여과, 예를 들어 나일론 등을 이용해 입자를 걸러내거나 냉동여과법 등을 이용해 여과한 후, 그대로 사용하거나 이를 동결건조, 열풍건조, 분무건조 등을 이용해 건조시켜 사용할 수 있다.In the present invention, the extract extracted with hot water or cold needle is filtered to remove floating solid particles, for example, nylon, etc. to filter the particles, or after filtration using a freeze filtration method, etc., or use as such, or freeze drying, hot air drying, It can be used after drying by spray drying or the like.
본 발명에서 사용되는 용어, "분획물"은 여러 다양한 구성 성분들을 포함하는 혼합물로부터 특정 성분 또는 특정 성분 그룹을 분리하기 위하여 분획을 수행하여 얻어진 결과물을 의미한다.As used herein, the term "fraction" means a result obtained by performing fractionation in order to separate a specific component or a specific component group from a mixture containing several different constituents.
본 발명에서 상기 분획물을 얻는 분획 방법은 특별히 제한되지 아니하며, 당해 기술 분야에서 통상적으로 사용하는 방법에 따라 수행될 수 있다. 상기 분획 방법의 비제한적인 예로는, 일당귀, 산수유, 녹용, 선백리향 또는 이들의 혼합물을 추출하여 얻은 추출물에 소정의 용매를 처리하여 상기 추출물로부터 분획물을 얻는 방법을 들 수 있다.The fractionation method for obtaining the fraction in the present invention is not particularly limited, and may be performed according to a method commonly used in the art. Non-limiting examples of the fractionation method may include a method of obtaining a fraction from the extract by treating an extract obtained by extracting Angelicae, Cornus, antler, Sun thyme, or a mixture thereof with a predetermined solvent.
본 발명에서 상기 분획물을 얻는 데에 사용되는 용매의 종류는 특별히 제한되지 아니하며, 당해 기술 분야에서 공지된 임의의 용매를 사용할 수 있다. 상기 분획 용매의 비제한적인 예로는 물, 알코올 등의 극성 용매; 헥산 (Hexane), 에틸 아세테이트 (Ethyl acetate), 클로로포름 (Chloroform), 디클로로메탄 (Dichloromethane) 등의 비극성 용매 등을 들 수 있다. 이들은 단독으로 사용되거나 2 종 이상 혼합하여 사용될 수 있다. 상기 분획 용매 중 알코올을 사용하는 경우에는 바람직하게는 C1 내지 C4의 알코올을 사용할 수 있다.In the present invention, the type of solvent used to obtain the fraction is not particularly limited, and any solvent known in the art may be used. Non-limiting examples of the fractionation solvent include polar solvents such as water and alcohol; Non-polar solvents, such as hexane (Hexane), ethyl acetate (Ethyl acetate), chloroform (Chloroform), and dichloromethane (Dichloromethane), etc. are mentioned. These may be used alone or in combination of two or more. In the case of using an alcohol in the fractionation solvent, preferably a C 1 to C 4 alcohol may be used.
본 발명의 일당귀추출물, 산수유추출물, 녹용추출물, 선백리향추출물 또는 일당귀, 산수유, 녹용 및 선백리향의 혼합추출물은 멜라닌의 생성을 효과적으로 저해하는 효능이 있으며, 구체적으로 합성되는 멜라닌의 총량을 감소시키는 효능을 나타낸다. 또한, 본 발명의 상기 조성물은 천연물 유래의 물질이어서 독성이 없으며, 인체에 적용하여도 부작용이 유발되지 않아 화장료 조성물로 활용될 수 있다.Angelicae extract, cornus oil extract, deer antler extract, thyme extract or a mixed extract of antler, cornus deer antler and sun thyme of the present invention has the effect of effectively inhibiting the production of melanin, and specifically the effect of reducing the total amount of melanin synthesized Represents. In addition, since the composition of the present invention is a material derived from a natural product, it is not toxic, and even when applied to the human body, side effects are not caused, so it can be used as a cosmetic composition.
멜라닌은 멜라노사이트에서 생성되는 흑갈색의 색소로서 사람의 피부색을 결정하며 멜라닌 색소억제로 피부를 밝게 하는 효능을 기대할 수 있다.Melanin is a dark brown pigment produced from melanocytes, which determines the color of human skin, and can be expected to brighten skin by inhibiting melanin pigment.
상기 효능과 관련하여 본 발명의 구체적인 실시예에 따르면, 마우스 멜라노마 세포(B-16 mouse melanoma cell)에 일당귀추출물, 산수유추출물, 녹용추출물, 선백리향추출물 또는 일당귀, 산수유, 녹용 및 선백리향의 혼합추출물을 농도별로 처리한 경우, 멜라노마 세포의 멜라닌의 총량이 감소되는 것으로 확인되었다(실시예 6).In relation to the above efficacy, according to a specific embodiment of the present invention, in mouse melanoma cells (B-16 mouse melanoma cells), a mixture of an angelfish extract, cornus milk extract, antler extract, sun thyme extract or an angelfish, cornus milk, antler and sun thyme When the extract was treated by concentration, it was confirmed that the total amount of melanin in melanoma cells was reduced (Example 6).
특히, 본 발명의 일당귀, 산수유, 녹용 및 선백리향을 모두 포함하는 혼합물의 추출물 또는 이의 분획물은 추출물들 간의, 및/또는 추출물 내 유효성분들 간의 시너지 효과 또는 협업 작용에 의하여 상기 각각의 식물의 단독 추출물에 비해 더욱 우수한 피부 미백 및 안색 개선 효능을 나타낼 수 있으며, 이는 본 발명에서 최초로 규명된 것이다.In particular, the extract of the mixture containing all of the Angelicae, Cornus, deer antler and Sun thyme of the present invention or a fraction thereof is a single extract of each plant by synergistic or cooperative action between the extracts and/or the active ingredients in the extract Compared to that, it can exhibit a more excellent skin whitening and complexion improvement effect, which was first identified in the present invention.
구체적으로, 본 발명의 일당귀, 산수유, 녹용 및 선백리향을 모두 포함하는 혼합물의 추출물 또는 이의 분획물은 일당귀, 산수유, 녹용 또는 선백리향의 단독 추출물에 비해 멜라노마 세포의 멜라닌 총량을 더욱 감소시켜 결과적으로 더욱 우수한 피부 미백 및 안색 개선 효능을 나타낼 수 있다.Specifically, the extract of the mixture containing all of the Angelicae, Cornus, deer antler and Seon thyme of the present invention, or a fraction thereof, further reduces the total amount of melanin in melanoma cells compared to the sole extract of Angelicae, Cornus, Deer antler or Seon Thyme. It may exhibit more excellent skin whitening and complexion improvement effects.
본 발명에서, 상기 일당귀, 산수유, 녹용 및 선백리향의 혼합 비율은 중량 기준으로 바람직하기로 10 내지 40 : 10 내지 40 : 10 내지 40 : 10 내지 40, 더욱 바람직하기로 20 내지 30: 20 내지 30 : 20 내지 30 : 20 내지 30일 수 있다.In the present invention, the mixing ratio of the angelica, cornus, antler and thyme is preferably 10 to 40: 10 to 40: 10 to 40: 10 to 40, more preferably 20 to 30: 20 to 30 by weight. : 20 to 30: It may be 20 to 30.
본 발명의 구체적인 실시예에 따르면, 상기 일당귀, 산수유, 녹용 및 선백리향의 혼합 비율이 25 : 25 : 25 : 25 인 혼합추출물을 제조하여 이들의 멜라노마 세포의 멜라닌 총량 감소 정도를 조사한 결과, 멜라노마 세포의 멜라닌 총량 감소 정도가 상기 일당귀, 산수유, 녹용 또는 선백리향의 단일 추출물에 비해 더욱 커지는 것으로 확인되었다(실시예 6).According to a specific embodiment of the present invention, as a result of investigating the degree of reduction in the total amount of melanin in the melanoma cells by preparing a mixed extract having a blending ratio of the angel angelfish, cornus milk, antler and sun thyme being 25:25:25:25, melanoma It was confirmed that the degree of reduction in the total amount of melanin in norma cells was greater than that of the single extracts of Angelica, Cornus, antler, or Seon thyme (Example 6).
본 발명에서 사용되는 용어, "미백"이란 멜라닌의 합성을 저해하여 멜라닌의 피부 침착을 억제하거나 방지하는 모든 작용을 의미한다.The term "whitening" used in the present invention refers to any action of inhibiting or preventing melanin deposition by inhibiting the synthesis of melanin.
본 발명에서 사용되는 용어, "안색 개선"이란 안면의 기미, 주근깨, 검버섯 등의 피부 잡티가 제거되거나 생성이 억제되고 피부 톤이 밝아져 안면의 전반적인 색이 미관상 개선되는 것을 의미한다.As used herein, the term "improving complexion" means that skin blemishes such as spots, freckles, and age spots on the face are removed or produced is suppressed, and the skin tone is brightened, so that the overall color of the face is improved aesthetically.
본 발명의 화장료 조성물은 용액, 외용 연고, 크림, 폼, 영양 화장수, 유연 화장수, 팩, 유연수, 유액, 메이크업 베이스, 에센스, 비누, 액체 세정료, 입욕제, 선 스크린 크림, 선 오일, 현탁액, 유탁액, 페이스트, 겔, 로션, 파우더, 비누, 계면 활성제-함유 클렌징, 오일, 분말 파운데이션, 유탁액 파운데이션, 왁스 파운데이션, 패취 및 스프레이로 구성된 군으로부터 선택되는 제형으로 제조할 수 있으나, 이에 제한되는 것은 아니다.The cosmetic composition of the present invention is a solution, external ointment, cream, foam, nutrient lotion, flexible lotion, pack, softening water, emulsion, makeup base, essence, soap, liquid detergent, bathing agent, sunscreen cream, sun oil, suspension, emulsion It can be prepared in a formulation selected from the group consisting of liquid, paste, gel, lotion, powder, soap, surfactant-containing cleansing, oil, powder foundation, emulsion foundation, wax foundation, patch, and spray, but is limited thereto. no.
본 발명의 상기 화장료 조성물은 일반 피부 화장료에 배합되는 화장품학적으로 허용 가능한 담체를 1 종 이상 추가로 포함할 수 있으며, 통상의 성분으로 예를 들면 유분, 물, 계면 활성제, 보습제, 저급 알코올, 증점제, 킬레이트제, 색소, 방부제, 향료 등을 적절히 배합할 수 있으나, 이에 제한되는 것은 아니다.The cosmetic composition of the present invention may additionally include one or more cosmetically acceptable carriers blended in general skin cosmetics, and as common ingredients, for example, oil, water, surfactants, moisturizers, lower alcohols, thickeners , A chelating agent, a colorant, a preservative, a fragrance, and the like may be appropriately blended, but are not limited thereto.
본 발명의 화장료 조성물에 포함되는 화장품학적으로 허용 가능한 담체는 화장료 조성물의 제형에 따라 다양하다.The cosmetically acceptable carrier included in the cosmetic composition of the present invention varies depending on the formulation of the cosmetic composition.
본 발명의 제형이 연고, 페이스트, 크림 또는 젤인 경우에는, 담체 성분으로서 동물성 유, 식물성 유, 왁스, 파라핀, 전분, 트라칸트, 셀룰로오스 유도체, 폴리에틸렌 글리콜, 실리콘, 벤토나이트, 실리카, 탈크, 산화 아연 등이 이용될 수 있으나, 이에 제한되는 것은 아니다. 이들은 단독으로 사용되거나 2 종 이상 혼합되어 사용될 수 있다.When the formulation of the present invention is an ointment, paste, cream or gel, animal oil, vegetable oil, wax, paraffin, starch, tracant, cellulose derivative, polyethylene glycol, silicone, bentonite, silica, talc, zinc oxide, etc. May be used, but is not limited thereto. These may be used alone or in combination of two or more.
본 발명의 제형이 파우더 또는 스프레이인 경우에는, 담체 성분으로서 락토스, 탈크, 실리카, 알루미늄 히드록사이드, 칼슘 실케이트, 폴리아미드 파우더 등이 이용될 수 있고, 특히 스프레이인 경우에는 추가적으로 클로로플루오로하드로카본, 프로판/부탄 또는 디메틸 에테르와 같은 추진제를 포함할 수 있으나, 이에 제한되는 것은 아니다. 이들은 단독으로 사용되거나 2 종 이상 혼합되어 사용될 수 있다.When the formulation of the present invention is a powder or spray, lactose, talc, silica, aluminum hydroxide, calcium silicate, polyamide powder, etc. may be used as a carrier component. In particular, in the case of a spray, additional chlorofluorohard It may include a propellant such as locarbon, propane/butane or dimethyl ether, but is not limited thereto. These may be used alone or in combination of two or more.
본 발명의 제형이 용액 또는 유탁액인 경우에는, 담체 성분으로서 용매, 용해화제 또는 유탁화제 등이 이용될 수 있으며, 예컨대 물, 에탄올, 이소프로판올, 에틸 카보네이트, 에틸 아세테이트, 벤질 알코올, 벤질 벤조에이트, 프로필렌 글리콜, 1,3-부틸글리콜 오일 등이 이용될 수 있고, 특히, 목화씨 오일, 땅콩 오일, 옥수수 배종 오일, 올리브 오일, 피마자 오일 및 참깨 오일, 글리세롤 지방족 에스테르, 폴리에틸렌 글리콜 또는 소르비탄의 지방산 에스테르가 이용될 수 있으나, 이에 제한되는 것은 아니다. 이들은 단독으로 사용되거나 2 종 이상 혼합되어 사용될 수 있다.When the formulation of the present invention is a solution or emulsion, a solvent, a solubilizing agent or an emulsifying agent may be used as a carrier component, such as water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, Propylene glycol, 1,3-butyl glycol oil, and the like may be used, and in particular, cottonseed oil, peanut oil, corn germ oil, olive oil, castor oil and sesame oil, glycerol aliphatic ester, polyethylene glycol or fatty acid ester of sorbitan May be used, but is not limited thereto. These may be used alone or in combination of two or more.
본 발명의 제형이 현탁액인 경우에는, 담체 성분으로서 물, 에탄올 또는 프로필렌 글리콜과 같은 액상의 희석제, 에톡실화 이소스테아릴 알코올, 폴리옥시에틸렌 소르비톨 에스테르 및 폴리옥시에틸렌 소르비탄 에스테르와 같은 현탁제, 미소결정성 셀룰로오스, 알루미늄 메타하이드록시드, 벤토나이트, 아가 또는 트라칸트 등이 이용될 수 있으나, 이에 제한되는 것은 아니다. 이들은 단독으로 사용되거나 2 종 이상 혼합되어 사용될 수 있다.When the formulation of the present invention is a suspension, as a carrier component, a liquid diluent such as water, ethanol or propylene glycol, an ethoxylated isostearyl alcohol, a suspending agent such as polyoxyethylene sorbitol ester and polyoxyethylene sorbitan ester, micro Crystalline cellulose, aluminum metahydroxide, bentonite, agar, or tracant may be used, but are not limited thereto. These may be used alone or in combination of two or more.
본 발명의 제형이 비누인 경우에는, 담체 성분으로서 지방산의 알칼리 금속 염, 지방산 헤미에스테르 염, 지방산 단백질 히드롤리제이트, 이세티오네이트, 라놀린 유도체, 지방족 알코올, 식물성 유, 글리세롤, 당 등이 이용될 수 있으나, 이에 제한되는 것은 아니다. 이들은 단독으로 사용되거나 2 종 이상 혼합되어 사용될 수 있다.When the formulation of the present invention is a soap, an alkali metal salt of a fatty acid, a fatty acid hemiester salt, a fatty acid protein hydrolyzate, isethionate, a lanolin derivative, an aliphatic alcohol, vegetable oil, glycerol, sugar, etc. are used as a carrier component. It may be, but is not limited thereto. These may be used alone or in combination of two or more.
본 발명의 화장료 조성물에서, 일당귀, 산수유, 녹용, 선백리향 또는 이들의 혼합물의 한약재 추출물은 바람직하게는 건조 중량으로, 화장료 조성물 총 중량의 0.0001 내지 50 중량%로 포함될 수 있으며, 보다 바람직하게는 0.0005 내지 10 중량%로 포함되는 것이 바람직하다. 상기 범위 내에서 우수한 미백 및 안색개선 효능을 나타내는 이점이 있으며, 조성물의 제형이 안정화되는 이점이 있다.
In the cosmetic composition of the present invention, the herbal extracts of Angelicae, Cornus, Deer antler, Sun thyme or a mixture thereof may be included in a dry weight, 0.0001 to 50% by weight of the total weight of the cosmetic composition, and more preferably 0.0005 It is preferably included in to 10% by weight. There is an advantage of showing excellent whitening and complexion improvement efficacy within the above range, and there is an advantage of stabilizing the formulation of the composition.
본 발명의 일당귀, 산수유, 녹용, 선백리향 또는 이들의 혼합물의 추출물 또는 이의 분획물을 함유하는 조성물은 피부 미백 효능이 우수하다. 구체적으로 본 발명의 조성물은 멜라닌 총량 증가를 억제하는 효능이 우수하다.The composition containing the extract or a fraction thereof of the Angelicae, Cornus, antler, Sun thyme or a mixture thereof of the present invention is excellent in skin whitening effect. Specifically, the composition of the present invention is excellent in the efficacy of inhibiting the increase in the total amount of melanin.
또한, 본 발명의 조성물은 천연물 유래의 물질이어서 독성이 없으며, 인체에 적용하여도 부작용을 유발하지 않아 화장료 조성물로의 활용도가 높다.
In addition, since the composition of the present invention is a material derived from a natural product, it is not toxic, and even when applied to the human body, it does not cause side effects, so its utilization as a cosmetic composition is high.
이하, 실시예를 통하여 본 발명의 구성 및 효과를 더욱 상세히 설명하고자 한다. 이들 실시예는 오로지 본 발명을 예시하기 위한 것일 뿐 본 발명의 범위가 이들 실시예에 의해 제한되는 것은 아니다.
Hereinafter, the configuration and effects of the present invention will be described in more detail through examples. These examples are for illustrative purposes only, and the scope of the present invention is not limited by these examples.
실시예Example 1: One: 일당귀추출물의Of the daily angelica extract 제조 Produce
일당귀를 건조하여 세절한 후, 건조중량 100g을 플라스크에 넣고 추출용매(증류수:1,3-부틸렌글리콜 = 7:3) 1000g으로 3일간 냉침하여 추출하였다. 냉침된 추출물을 0.2㎛의 기공 크기를 가진 필터로 여과하여 일당귀추출물을 제조하였다.
After drying and slicing, 100 g of dry weight was added to a flask and extracted by cold soaking for 3 days with 1000 g of an extraction solvent (distilled water: 1,3-butylene glycol = 7:3). The cold-precipitated extract was filtered through a filter having a pore size of 0.2 µm to prepare a daily angelica extract.
실시예Example 2: 산수유추출물의 제조 2: Preparation of Cornus oil extract
산수유를 건조하여 세절한 후, 건조중량 100g을 플라스크에 넣고 추출용매(증류수:1,3-부틸렌글리콜 = 7:3) 1000g으로 3일간 냉침하여 추출하였다. 냉침된 추출물을 0.2㎛의 기공 크기를 가진 필터로 여과하여 산수유추출물을 제조하였다.
After drying and mincing the cornus oil, 100 g of dry weight was put into a flask and extracted by cold soaking for 3 days with 1000 g of an extraction solvent (distilled water: 1,3-butylene glycol = 7:3). The cold-precipitated extract was filtered through a filter having a pore size of 0.2 µm to prepare a cornus oil extract.
실시예Example 3: 녹용추출물의 제조 3: Preparation of antler extract
녹용을 건조하여 세절한 후, 건조중량 100g을 플라스크에 넣고 추출용매(증류수:1,3-부틸렌글리콜 = 7:3) 1000g으로 3일간 냉침하여 추출하였다. 냉침된 추출물을 0.2㎛의 기공 크기를 가진 필터로 여과하여 녹용추출물을 제조하였다.
After the antler was dried and minced, 100 g of dry weight was put into a flask, and extracted by cold soaking with 1000 g of an extraction solvent (distilled water: 1,3-butylene glycol = 7:3) for 3 days. The chilled extract was filtered through a filter having a pore size of 0.2 μm to prepare an antler extract.
실시예Example 4: 4: 선백리향추출물의Sun thyme extract 제조 Produce
선백리향을 건조하여 세절한 후, 건조중량 100g을 플라스크에 넣고 추출용매(증류수:1,3-부틸렌글리콜 = 7:3) 1000g으로 3일간 냉침하여 추출하였다. 냉침된 추출물을 0.2㎛의 기공 크기를 가진 필터로 여과하여 선백리향추출물을 제조하였다.
After drying and mincing the sun thyme, 100 g of dry weight was put into a flask, and extracted by cold soaking for 3 days with 1000 g of an extraction solvent (distilled water: 1,3-butylene glycol = 7:3). The chilled extract was filtered through a filter having a pore size of 0.2 μm to prepare a sun thyme extract.
실시예Example 5: 5: 일당귀An angel , 산수유, 녹용 및 , Cornus, antler and 선백리향의Thyme 혼합추출물의 제조 Preparation of mixed extract
일당귀, 산수유, 녹용 및 선백리향을 건조하여 세절한 후, 건조중량 100g(일당귀 25g, 산수유 25g, 녹용 25g, 선백리향 25g)을 플라스크에 넣고 추출용매(증류수:1,3-부틸렌글리콜 = 7:3) 1000g으로 3일간 냉침하여 추출하였다. 냉침된 추출물을 0.2㎛의 기공 크기를 가진 필터로 여과하여 일당귀, 산수유, 녹용 및 선백리향의 혼합추출물을 제조하였다.
After drying and slicing the angelica, cornus oil, antler and thyme, 100g of dry weight (25g of cornflower, 25g of cornus, 25g of deer antler, 25g of sun thyme) was added to the flask and extraction solvent (distilled water: 1,3-butylene glycol = 7 :3) 1000g was extracted by cold soaking for 3 days. The cold-precipitated extract was filtered through a filter having a pore size of 0.2 µm to prepare a mixed extract of Japanese angelfish, cornus milk, antler and sun thyme.
실시예Example 6: 미백 효과-멜라닌 총량 감소 효과 조사 6: Whitening effect-Investigation of the effect of reducing the total amount of melanin
상기 실시예 1 내지 5의 추출물을 쥐의 멜라노마 세포(B-16 mouse melanoma cell)의 배양액에 첨가하여 세포 수준에서의 미백 효과를 실험하였다. 비교를 위하여, 음성 대조군에는 별도의 처리를 하지 않았으며, 양성 대조군에는 알부틴을 첨가하였다.The extracts of Examples 1 to 5 were added to the culture medium of mouse melanoma cells (B-16 mouse melanoma cells) to test the whitening effect at the cellular level. For comparison, no separate treatment was applied to the negative control group, and arbutin was added to the positive control group.
구체적으로, 실시예 1 내지 5의 한약재추출물에 대하여 최종농도(중량%)가 0.1% 또는 1%가 되도록 하여 실험하였으며, 양성 대조군인 알부틴은 200㎍/ml가 되도록 배지에 첨가하여 각각 B-16 멜라노마 세포에 처리하여 3일간 배양하였다.Specifically, the final concentration (% by weight) of the herbal medicine extracts of Examples 1 to 5 was tested to be 0.1% or 1%, and arbutin, a positive control, was added to the medium so that it became 200 μg/ml, respectively, and B-16 The melanoma cells were treated and cultured for 3 days.
이후, 세포들을 트립신(trypsin) 처리하여 배양용기로부터 떼어내 원심분리 한 후 멜라닌을 추출하였다. 떼어낸 세포는 수산화 나트륨 용액(1N 농도) 1ml를 가하여 10분간 끓여 멜라닌을 녹이고 분광 광도계를 이용하여, 400나노미터(nm)에서 흡광도를 측정하여 생성된 멜라닌의 양을 측정하였다. Thereafter, the cells were treated with trypsin, removed from the culture vessel, centrifuged, and melanin was extracted. The detached cells were boiled for 10 minutes by adding 1 ml of sodium hydroxide solution (1N concentration) to dissolve melanin, and the absorbance was measured at 400 nanometers (nm) using a spectrophotometer to measure the amount of melanin produced.
상기 멜라닌 양은 단위 세포수당(106 cell)의 흡광도(Absorbance)로 나타내는 방법으로 측정하였으며, 음성 대조군에 대한 상대적인 멜라닌 총량에 대한 저해율(%)로 계산하고 결과를 하기 표 1에 나타내었다. 또한, 실험은 3번 반복된 것이다.
The amount of melanin was measured by a method of expressing the absorbance per unit cell count (10 6 cells), and was calculated as an inhibition rate (%) for the total amount of melanin relative to the negative control, and the results are shown in Table 1 below. Also, the experiment was repeated 3 times.
시료(%)sample(%)
상기 표 1의 결과에서 볼 수 있듯이, 일당귀추출물, 산수유추출물, 녹용추출물, 선백리향추출물 및 이들 한약재의 혼합추출물은 멜라닌 합성을 억제하여 멜라닌의 총량을 감소시키는 효능이 있으며, 4가지 한약재를 혼합하여 추출한 실시예 5의 경우 각각의 한약재 단독추출물에 비해 멜라닌의 총량을 더욱 크게 감소시키는 효능이 있음을 알 수 있었으며, 종래 알려진 미백 물질인 알부틴과 유사한 정도로 우수한 멜라닌 총량 감소 효능을 나타냄을 확인할 수 있었다.
As can be seen from the results of Table 1, the daily angelica root extract, cornus oil extract, antler extract, sun thyme extract, and mixed extracts of these herbal medicines have the effect of reducing the total amount of melanin by inhibiting melanin synthesis, and by mixing four herbal medicines In the case of the extracted Example 5, it was found that there is an effect of further significantly reducing the total amount of melanin compared to each of the herbal extracts alone, and it was confirmed that the total amount of melanin reduction effect was similar to that of arbutin, a conventional whitening substance.
제조예Manufacturing example 1: 본 발명의 혼합 추출물을 함유하는 에센스 제조 1: Preparation of essence containing the mixed extract of the present invention
하기의 표 2와 같이 에센스 제형의 화장료 조성물을 제조하였다(단위: 중량%).A cosmetic composition of an essence formulation was prepared as shown in Table 2 below (unit: wt%).
세테아릴글루코사이드
호호바씨오일
실리카
글리세린
실시예 5 추출물
정제수Cetearyl alcohol
Cetearyl glucoside
Jojoba seed oil
Silica
glycerin
Example 5 extract
Purified water
1
5
0.5
10
5
To 1002
One
5
0.5
10
5
To 100
제조예Manufacturing example 2: 본 발명의 혼합 추출물을 함유하는 크림 제조 2: Preparation of a cream containing the mixed extract of the present invention
하기의 표 3과 같이 크림 제형의 화장료 조성물을 제조하였다(단위: 중량%).As shown in Table 3 below, a cream-formed cosmetic composition was prepared (unit: wt%).
스테아린산
에탄올
수산화칼륨
글리세린
프로필렌글리콜
방부제
향
정제수Example 5 extract
Stearic acid
ethanol
Potassium hydroxide
glycerin
Propylene glycol
antiseptic
incense
Purified water
15.0
1.0
0.7
5.0
3.0
적량
적량
to 1005
15.0
1.0
0.7
5.0
3.0
Appropriate amount
Appropriate amount
to 100
Claims (7)
A cosmetic composition for whitening or improving complexion, characterized in that it comprises an extract of sun thyme or a fraction thereof as an active ingredient.
The cosmetic composition for whitening or improving complexion according to claim 1, comprising a mixed extract of Japanese angelica, cornus milk, antler and sun thyme, or a fraction thereof as an active ingredient.
The cosmetic composition for whitening or improving complexion according to claim 2, wherein the mixing ratio of the angelica branch, cornus milk, antler and sun thyme is 10 to 40:10 to 40:10 to 40:10 to 40 based on weight.
The cosmetic composition for whitening or improving complexion according to claim 3, wherein the mixing ratio of the angelfish, cornus milk, antler and sun thyme is 25:25:25:25 based on weight.
The method of claim 1, wherein the extract is obtained by extracting sun thyme with at least one solvent selected from the group consisting of water, C 1 to C 4 lower alcohol, 1,3-butylene glycol, and ethyl acetate. Cosmetic composition for whitening or improving complexion, characterized in that.
The cosmetic composition for whitening or improving complexion according to claim 5, wherein the solvent is a mixture of water and 1,3-butylene glycol in a weight ratio of 7:3.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020140081566A KR102168533B1 (en) | 2014-07-01 | 2014-07-01 | Cosmetic composition for whitening or improving the facial color containing herb extracts |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020140081566A KR102168533B1 (en) | 2014-07-01 | 2014-07-01 | Cosmetic composition for whitening or improving the facial color containing herb extracts |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20160003916A KR20160003916A (en) | 2016-01-12 |
KR102168533B1 true KR102168533B1 (en) | 2020-10-22 |
Family
ID=55169945
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020140081566A KR102168533B1 (en) | 2014-07-01 | 2014-07-01 | Cosmetic composition for whitening or improving the facial color containing herb extracts |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102168533B1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11701322B2 (en) | 2018-03-23 | 2023-07-18 | Mary Kay Inc. | Topical compositions and methods |
KR102073349B1 (en) * | 2019-03-11 | 2020-02-05 | 대한바이오팜 주식회사 | Composition for anti-wrinkle, skin whitening and antioxidation comprising medicinal herb extract |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR970021273A (en) * | 1995-10-25 | 1997-05-28 | 성재갑 | Whitening soap composition |
KR100345226B1 (en) * | 2001-08-29 | 2002-07-25 | 주식회사 태평양 | Whitening cosmetic composition including the extract of the fruits of Melia azedarach or M. toosendan |
KR100921947B1 (en) | 2003-11-19 | 2009-10-15 | (주)아모레퍼시픽 | Skin whitening cosmetic composition |
KR100923141B1 (en) | 2007-12-26 | 2009-10-23 | 부산대학교 산학협력단 | Skin whitening composition comprising arbutin beta derivative |
-
2014
- 2014-07-01 KR KR1020140081566A patent/KR102168533B1/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
KR20160003916A (en) | 2016-01-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101387308B1 (en) | Skin whitening composition by using of dendropanax morbifera ferment extract | |
KR101525873B1 (en) | Cosmetic composition containing Manufacturing method and Cultured wild Ginseng Roots, Hedysarum ussuriensis, Sophora flavescens and Adenophora triphylla by two-stage fermentation for improving skin | |
KR101825704B1 (en) | A cosmetic composition comprising coffee silver skin extract | |
KR101350292B1 (en) | Cosmetic composition containing fermented extracts of panax ginseng root, ganoderma lucidum and white tea and method for preparing the same | |
KR101685251B1 (en) | Cosmetic composition comprising extract of Brassica Rapa, Brassica Rapa radish leaves or Brassica Rapa callus with anti-oxidant, astringent activity and skin wrinkle improvement effect and the manufacturing method thereof | |
KR101890828B1 (en) | Functional cosmetic composition and manufacturing method thereof | |
KR102168532B1 (en) | Cosmetic composition for enhancing skin elasticity or improving skin wrinkle containing herb extracts | |
KR20170137465A (en) | Composition for improving skin condition comprising herb extracts mixture | |
KR20170076147A (en) | Composition for improving skin | |
KR102168533B1 (en) | Cosmetic composition for whitening or improving the facial color containing herb extracts | |
KR102130243B1 (en) | A cosmetic composition for skin whitening, anti-wrinkle, anti-aging, and anti-oxidation containing glutathione, natural spicule powder, acetyl hexapeptide and broussonetia kazinoki extract | |
CN106413687B (en) | Product and its preparation method and application containing gadol extract and ginkgo biloba extract | |
KR102056263B1 (en) | A cosmetic composition comprising extract of coffee silver skin and coffee grounds | |
KR20170136919A (en) | Composition for improving skin condition comprising herb extracts mixture | |
KR20170137549A (en) | Composition for improving skin condition comprising herb extracts mixture | |
KR100789632B1 (en) | Skin whitening cosmetics containing plant extracts with melanin inhibitory activity | |
KR101854766B1 (en) | Skin whitening complex containing trihydroxyisoflavone and glycyrrhiza uralensis extracts | |
KR20160003918A (en) | Cosmetic composition for enhancing skin elasticity or improving skin wrinkle containing herb extracts | |
KR102202554B1 (en) | Skin whitening cosmetic composition with the extract of Saururus chinensis leaf, the extract of Grape seed, the extract of Portulaca oleracea and rice fermented product | |
KR101256180B1 (en) | Cosmetic composition comprising extract of thin film outer cover of Luffa Roemer seed for skin whitening | |
KR101317433B1 (en) | The cosmetic composition for skin whitening comprising the mixture of extract of Hovenia dulcia, Platycodon grandiflorum, wheat bud and sage | |
KR20170137405A (en) | Composition for improving skin condition comprising herb extracts mixture | |
KR101176525B1 (en) | Cosmetic Composition Comprising Acer tegmentosum Maxim as Active Ingredient | |
KR101117560B1 (en) | Cosmetic Composition for Improving Skin Flexibility Comprising The Boyangaek | |
KR102692062B1 (en) | A cosmetic composition having anti-oxidant, anti-inflammatory, protection of skin cell induced by ultraviolet ray and skin whitening effects comrising camellia sinensis extract, rumex crispus extract and inula britannica extract |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20140701 |
|
PG1501 | Laying open of application | ||
A201 | Request for examination | ||
PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20181127 Comment text: Request for Examination of Application Patent event code: PA02011R01I Patent event date: 20140701 Comment text: Patent Application |
|
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20200318 Patent event code: PE09021S01D |
|
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20201007 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20201015 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20201016 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration |